Bennett C. Frank, EVP and Chief Scientific Officer at Ionis Pharmaceuticals ($IONS), sold about $18.1 million in company shares across 12 open market transactions over the last 365 days. His most recent sale occurred on March 3, 2026. These sales rank him 723rd among 11,678 insiders by total value sold, above the average of $8.6 million per insider and 6.4 transactions. Frank made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 16463 | $32.60 | 117,017.0000 | 158,964,772 | 16.37% | 0.01% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Non-Qualified Stock Option (right to buy) | 48626 | $0.00 | 0.0000 | 158,964,772 | 100.00% | 0.03% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 802 | $80.76 | 80,554.0000 | 158,964,772 | 0.99% | 0.00% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Non-Qualified Stock Option (right to buy) | 16463 | $0.00 | 2,406.0000 | 158,964,772 | 87.25% | 0.01% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 12687 | $79.88 | 81,356.0000 | 158,964,772 | 13.49% | 0.01% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 71600 | $79.10 | 94,043.0000 | 158,964,772 | 43.23% | 0.05% |
| March 3, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 48626 | $60.89 | 165,643.0000 | 158,964,772 | 41.55% | 0.03% |
| Feb. 27, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | J | Common Stock | 261 | $48.87 | 100,554.0000 | 158,964,772 | 0.26% | 0.00% |
| Feb. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | J | Common Stock | 0 | $0.00 | 100,293.0000 | 158,964,772 | 0.00% | 0.00% |
| Feb. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 20000 | $82.60 | 80,293.0000 | 158,964,772 | 19.94% | 0.01% |
| Feb. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 48626 | $83.03 | 80,293.0000 | 158,964,772 | 37.72% | 0.03% |
| Feb. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 48626 | $60.89 | 128,919.0000 | 158,964,772 | 60.56% | 0.03% |
| Feb. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Non-Qualified Stock Option (right to buy) | 48626 | $0.00 | 0.0000 | 158,964,772 | 100.00% | 0.03% |
| Feb. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Non-Qualified Stock Option (right to buy) | 16463 | $0.00 | 2,406.0000 | 158,964,772 | 87.25% | 0.01% |
| Feb. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 16463 | $83.03 | 80,293.0000 | 158,964,772 | 17.01% | 0.01% |
| Feb. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 16463 | $32.60 | 96,756.0000 | 158,964,772 | 20.50% | 0.01% |
| Jan. 29, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Common Stock | 11421 | $0.00 | 106,178.0000 | 158,964,772 | 12.05% | 0.01% |
| Jan. 30, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 5885 | $82.95 | 100,293.0000 | 158,964,772 | 5.54% | 0.00% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Restricted Stock Unit | 9675 | $0.00 | 27,109.0000 | 158,964,772 | 55.50% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Performance Restricted Stock Units | 25800 | $0.00 | 89,282.0000 | 158,964,772 | 40.64% | 0.02% |
| Jan. 16, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 8977 | $75.15 | 94,757.0000 | 158,964,772 | 8.65% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 21055 | $0.00 | 103,734.0000 | 158,964,772 | 25.47% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Restricted Stock Unit | 21055 | $0.00 | 17,434.0000 | 158,964,772 | 54.70% | 0.01% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Non-Qualified Stock Option (right to buy) | 19350 | $0.00 | 19,350.0000 | 158,964,772 | 9999.99% | 0.01% |
| Sept. 5, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 6000 | $59.60 | 82,679.0000 | 158,964,772 | 6.77% | 0.00% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Non-Qualified Stock Option (right to buy) | 46800 | $0.00 | 0.0000 | 158,964,772 | 100.00% | 0.03% |
| Sept. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 5000 | $49.14 | 88,679.0000 | 158,964,772 | 5.34% | 0.00% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 33909 | $60.62 | 101,570.0000 | 158,964,772 | 25.03% | 0.02% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 12891 | $61.50 | 88,679.0000 | 158,964,772 | 12.69% | 0.01% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 46800 | $53.77 | 135,479.0000 | 158,964,772 | 52.77% | 0.03% |
| Aug. 29, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | J | Common Stock | 213 | $27.71 | 93,679.0000 | 158,964,772 | 0.23% | 0.00% |
| Aug. 18, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Non-Qualified Stock Option (right to buy) | 10000 | $0.00 | 18,869.0000 | 158,964,772 | 34.64% | 0.01% |
| Aug. 18, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 10000 | $32.60 | 103,466.0000 | 158,964,772 | 10.70% | 0.01% |
| Aug. 18, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 10000 | $43.98 | 93,466.0000 | 158,964,772 | 9.67% | 0.01% |
| Feb. 28, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | J | Common Stock | 320 | $28.21 | 93,466.0000 | 158,964,772 | 0.34% | 0.00% |
| Jan. 31, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 1327 | $32.46 | 93,146.0000 | 0 | 1.40% | 0.00% |
| Jan. 30, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Common Stock | 3607 | $0.00 | 94,473.0000 | 0 | 3.97% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Restricted Stock Unit | 33000 | $0.00 | 56,500.0000 | 0 | 140.43% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 18011 | $0.00 | 97,618.0000 | 0 | 22.62% | 0.00% |
| Jan. 16, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 6752 | $32.90 | 90,866.0000 | 0 | 6.92% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Performance Restricted Stock Units | 22000 | $0.00 | 63,482.0000 | 0 | 53.04% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Restricted Stock Unit | 18011 | $0.00 | 38,489.0000 | 0 | 31.88% | 0.00% |
| Jan. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Non-Qualified Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 1885 | $49.52 | 79,047.0000 | 0 | 2.33% | 0.00% |
| Aug. 30, 2024 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | J | Common Stock | 177 | $38.64 | 79,607.0000 | 0 | 0.22% | 0.00% |
| Feb. 29, 2024 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | Officer Level 14 | J | Common Stock | 383 | $34.43 | 79,462.0000 | 0 | 0.48% | 0.00% |
| Feb. 1, 2024 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Common Stock | 3609 | $0.00 | 80,932.0000 | 0 | 4.67% | 0.00% |
| Feb. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 1853 | $49.52 | 79,079.0000 | 0 | 2.29% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Restricted Stock Unit | 18314 | $0.00 | 23,500.0000 | 0 | 43.80% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 18314 | $0.00 | 84,068.0000 | 0 | 27.85% | 0.00% |
| Jan. 17, 2024 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 6745 | $50.42 | 77,323.0000 | 0 | 8.02% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Restricted Stock Unit | 20400 | $0.00 | 41,814.0000 | 0 | 95.26% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Performance Restricted Stock Units | 17000 | $0.00 | 41,482.0000 | 0 | 69.44% | 0.00% |
| Jan. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Non-Qualified Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| Dec. 21, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Non-Qualified Stock Option (right to buy) | 16113 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 20, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Non-Qualified Stock Option (right to buy) | 6500 | $0.00 | 16,113.0000 | 0 | 28.74% | 0.00% |
| Dec. 21, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 16113 | $49.29 | 65,754.0000 | 0 | 19.68% | 0.00% |
| Dec. 21, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 16113 | $47.34 | 81,867.0000 | 0 | 24.50% | 0.00% |
| Dec. 20, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 6500 | $49.64 | 65,754.0000 | 0 | 9.00% | 0.00% |
| Dec. 20, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 6500 | $47.34 | 72,254.0000 | 0 | 9.89% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 8610 | $47.34 | 74,364.0000 | 0 | 13.09% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 8610 | $50.19 | 65,754.0000 | 0 | 11.58% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 14002 | $49.21 | 65,754.0000 | 0 | 17.56% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Non-Qualified Stock Option (right to buy) | 8610 | $0.00 | 22,613.0000 | 0 | 27.58% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 14002 | $47.34 | 79,756.0000 | 0 | 21.29% | 0.00% |
| Dec. 14, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Non-Qualified Stock Option (right to buy) | 14002 | $0.00 | 31,223.0000 | 0 | 30.96% | 0.00% |
| Sept. 28, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 4460 | $46.50 | 65,754.0000 | 0 | 6.35% | 0.00% |
| Aug. 31, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | Officer Level 14 | J | Common Stock | 180 | $30.56 | 70,214.0000 | 0 | 0.26% | 0.00% |
| Feb. 28, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | J | Common Stock | 383 | $30.52 | 70,034.0000 | 0 | 0.55% | 0.00% |
| Feb. 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Common Stock | 3609 | $0.00 | 71,464.0000 | 0 | 5.32% | 0.00% |
| Feb. 6, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 1813 | $40.57 | 69,651.0000 | 0 | 2.54% | 0.00% |
| Jan. 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Common Stock | 19417 | $0.00 | 74,833.0000 | 0 | 35.04% | 0.00% |
| Jan. 18, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | S | Common Stock | 6978 | $38.89 | 67,855.0000 | 0 | 9.32% | 0.00% |
| Jan. 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | M | Restricted Stock Unit | 19417 | $0.00 | 21,414.0000 | 0 | 47.55% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Restricted Stock Unit | 16387 | $0.00 | 40,831.0000 | 0 | 67.04% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Performance Restricted Stock Units | 13656 | $0.00 | 24,482.0000 | 0 | 126.14% | 0.00% |
| Jan. 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | BENNETT C FRANK | EVP, Chief Scientific Officer | A | Non-Qualified Stock Option (right to buy) | 21849 | $0.00 | 21,849.0000 | 0 | 9999.99% | 0.00% |